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ORIGINAL RESEARCH
The Circadian Clock Gene BMAL1 Coordinates
Intestinal Regeneration
Kyle Stokes,1 Abrial Cooke,1 Hanna Chang,1 David R. Weaver,2 David T. Breault,3,4,5,a and
Phillip Karpowicz1,a
1

Department of Biological Sciences, University of Windsor, Windsor, Ontario, Canada; 2Department of Neurobiology, University
of Massachusetts Medical School, Worcester, Massachusetts; 3Harvard Stem Cell Institute, Cambridge, Massachusetts;
4
Division of Endocrinology, Boston Children’s Hospital, Boston, Massachusetts; 5Department of Pediatrics, Harvard Medical
School, Boston, Massachusetts

SUMMARY
We investigated the circadian timing of intestinal regeneration
using the null mutant BMAL1. Our results show that the
circadian clock regulates the timing of inﬂammation and
proliferation during regeneration.
BACKGROUND & AIMS: The gastrointestinal syndrome is an
illness of the intestine caused by high levels of radiation. It is
characterized by extensive loss of epithelial tissue integrity, which
initiates a regenerative response by intestinal stem and precursor
cells. The intestine has 24-hour rhythms in many physiological
functions that are believed to be outputs of the circadian clock: a
molecular system that produces 24-hour rhythms in transcription/
translation. Certain gastrointestinal illnesses are worsened when
the circadian rhythms are disrupted, but the role of the circadian
clock in gastrointestinal regeneration has not been studied.
METHODS: We tested the timing of regeneration in the mouse
intestine during the gastrointestinal syndrome. The role of the
circadian clock was tested genetically using the BMAL1 loss of
function mouse mutant in vivo, and in vitro using intestinal
organoid culture.
RESULTS: The proliferation of the intestinal epithelium follows
a 24-hour rhythm during the gastrointestinal syndrome. The
circadian clock runs in the intestinal epithelium during this

pathologic state, and the loss of the core clock gene, BMAL1,
disrupts both the circadian clock and rhythmic proliferation.
Circadian activity in the intestine involves a rhythmic production of inﬂammatory cytokines and subsequent rhythmic activation of the JNK stress response pathway.
CONCLUSIONS: Our results show that a circadian rhythm in
inﬂammation and regeneration occurs during the gastrointestinal
syndrome. The study and treatment of radiation-induced illnesses,
and other gastrointestinal illnesses, should consider 24-hour timing
in physiology and pathology. (Cell Mol Gastroenterol Hepatol
2017;4:95–114; http://dx.doi.org/10.1016/j.jcmgh.2017.03.011)
Keywords: Intestine; Circadian Rhythms; Gastrointestinal
Syndrome; TNF; Intestinal Stem Cells.

a

Authors share co-senior authorship and contributed equally.

Abbreviations used in this paper: LD, light/dark; NFkB, nuclear factor
kB; PBS, phosphate-buffered saline; pHH3, phosphorylated histone
H3; pJUN, phosphorylated c-JUN; TNF, tumor necrosis factor; ZT,
Zeitgeber time.
Most current article

© 2017 The Authors. Published by Elsevier Inc. on behalf of the AGA
Institute. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2352-345X
http://dx.doi.org/10.1016/j.jcmgh.2017.03.011

96

Stokes et al

See editorial on page 203.

T

he intestinal epithelium can produce cells at a prodigious rate, and a long-standing question in the
ﬁeld is what mechanisms underlie its regeneration following
damage or stress. The epithelium is maintained by a population of stem cells that divide to produce transit-amplifying
precursors, differentiated enterocytes, goblet cells, Paneth
cells, and enteroendocrine cells.1 Stem cells and precursors
are localized to the base of the crypts of Lieberkühn, and
their progeny differentiate as they move upward toward the
villus. The use of radiation to damage the epithelium and
initiate a regenerative response is an important and clinically relevant model to study regeneration in the small
intestine.2,3
High levels of radiation induce the gastrointestinal syndrome,4–6 an illness associated with the loss of dividing
precursors and stem cells during the ﬁrst 24 hours, and
breakdown of the epithelial barrier, which leads to increased
permeability, infection, and extensive inﬂammation.6 This is
then followed by a regenerative response initiated from a
surviving population of stem cells. Understanding the
mechanisms underlying the gastrointestinal syndrome provides essential insight into intestinal regeneration, with the
potential for impacting patients exposed to ionizing radiation.
The timing of the molecular and cellular mechanisms, or
chronobiology, of the gastrointestinal syndrome is poorly
understood. In general, the importance of intestinal chronobiology is somewhat underappreciated, although 1 form
of timing, its circadian rhythms, has been studied extensively.7 Circadian rhythms are biologic processes that occur
with an approximate cycle of 24 hours. They are driven by a
highly conserved molecular pacemaker, called the circadian
clock, which produces 24-hour rhythms in animal behavior
and physiology.8 An example of a circadian rhythm is an
animal’s locomotor activity; when the clock is disrupted,
activity becomes arrhythmic.9
In mammals, the circadian clock consists of the transactivators CLK and BMAL1 (also called ARNTL) and their
negative regulators PER1-3 and CRY1-2.8,10 The transcriptional targets of CLK/BMAL1 include PER1-3 and CRY1-2,
which accumulate as proteins during the night to repress
their own expression. A second form of transcriptional control is driven by RORa and REV-ERBa (also called NR1D1) that
activate and repress BMAL1 expression, respectively. Posttranscriptional and posttranslational mechanisms also
contribute to rhythmicity.11 Photoperiod, ingested food, and
hormone levels synchronize circadian clocks throughout the
body to drive 24-hour transcriptional rhythms with characteristic maxima and minima at speciﬁc times of day. A
tremendous number of processes throughout the body are
inﬂuenced by the circadian clock. For example, more than
40% of the genome is expressed rhythmically, and in different
tissues 3%–16% of these genes are rhythmic, and include key
rate-limiting enzymes.12 Previous studies have shown that
circadian transcriptional rhythms are present in the digestive
tract,13–16 but their function has not been tested.
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Circadian rhythms are important in human health and, in
particular, inﬂuence several digestive system illnesses. Shiftworkers undergo photoperiod disruption and experience
higher rates of gastrointestinal pain,17 ulcers,18 and colorectal cancer.19 Experimental models also reveal that colitis
is worsened during photoperiod disruption,20 highlighting a
possible connection between circadian rhythms and intestinal inﬂammation. The response to gastrointestinal injury is
also time-dependent: patients with cancer treated with
radiotherapy have more severe intestinal mucositis when
irradiated in the morning versus in the evening.21 These
studies show that digestive tract physiology changes according to time of day, and that disruption to this timing has
negative consequences.
Although circadian rhythms are widespread throughout
the body, the circadian timing system is hierarchical.22 A
circadian clock in the suprachiasmatic nucleus of the hypothalamus receives light input from the retina to synchronize it to the daily light/dark (LD) cycle. Even in the
absence of light input, the suprachiasmatic nucleus generates rhythms in body temperature, food intake, and hormone levels that synchronize circadian clocks in other
tissues, such as the intestine, which normally receive synchronizing information originating in the brain. To what
extent does the intrinsic clock in the intestine regulate the
regenerative response? Despite data showing circadian
rhythms in the intestine and the immune system, studies of
gastrointestinal disease do not consider time-of-day effects.
To address this fundamental question we investigated
the timing of intestinal regeneration in the epithelium of
mice with the gastrointestinal syndrome, and found
diurnal rhythms in crypt cell proliferation. We next
investigated the role of the core circadian clock gene,
BMAL1, in the intestine before and after acute radiation
injury. Regeneration in this tissue is BMAL1-dependent,
which regulates daily timing of the JNK stress response
pathway activity and subsequent proliferation. Our data
suggest that cytokines, which are rhythmically expressed
in the intestine during regeneration, drive a circadian
stress response in the epithelium. By regulating the stress
response, BMAL1 promotes the 24-hour rhythmic production of intestinal epithelia. These data shed light on the
importance of the circadian clock during intestinal illness
and regeneration.

Materials and Methods
Animal Housing

BMAL1þ/þ and BMAL1-/- mouse littermates were bred
from BMAL1þ/- parents (Jackson Laboratories, Bar Harbor,
ME #009100), and were housed on a 12-hour light/12-hour
dark photoperiod with ad libitum food. We use the term
diurnal, rather than circadian, in the text because all of our
experiments were performed on a LD photoperiod, rather
than in the absence of circadian entrainment factors. All
mice were maintained according to animal care regulatory
approval at Boston Children’s Hospital (#A07 09 124R),
University of Massachusetts Medical School (#A-1315), or
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the University of Windsor (#AUPP 14-21). Gamma irradiation was performed at Zeitgeber time (ZT) 3 at 1.05 Gy/min
for a total of 12 Gy in 1 single treatment, and animals were
returned to 12-hour light/12-hour dark photoperiod with
ad libitum food, and Bactrim antibiotic (Hi Tech Pharmacal,
Amityville, NY) in drinking water following treatment. Intestinal tissues were sampled from irradiated mice, or
control (undamaged) animals housed under the same LD
photoperiod conditions, at Day 4, for 24 hours following
irradiation. A total of 3–4 mice were examined per condition
(normal conditions vs irradiation, genotype, time point).
Both female and male mice were included in the study,
because no signiﬁcant sex-linked differences were found in
all of the parameters examined in this study.

Intestinal Tissues
Animals were humanely euthanized using CO2 at 4-hour
time points over a day: ZT0, ZT4, ZT8, ZT12, ZT16, and
ZT20 as indicated in Figures 1–9. For data shown in
Figure 1B, tissue was collected at Day 0, 1, 2, 3, 4, and 5 at
ZT4. Samples of proximal intestine (10 cm of small intestine containing duodenum and a portion of the jejunum)
were collected for analysis. Samples were ﬂushed clean
using 4 mM sodium phosphate buffer pH7.4 þ 155 mM
saline (phosphate-buffered saline [PBS]). Each 10-cm
sample was further cut into 4–5 segments. A w0.5-cm
portion of each 2-cm segment was collected in RNAlater
buffer (Qiagen, Toronto, Ontario, Canada) and stored at
-80 C for RNA puriﬁcation. The remaining w1.5-cm segments of intestine were ﬁxed in 4% paraformaldehyde
(Electron Microscopy Sciences, Hatﬁeld, PA) þ PBS overnight at 4 C for immunoﬂuorescence and histology.

RNA Puriﬁcation and Analysis
In vivo tissue was homogenized in RLT Buffer (Qiagen)
using a Bullet Blender (Next Advance, Averill Park, NY)
according to the manufacturer’s protocol. Organoids (see
later) were lysed directly into RLT Buffer and vortexed until
the solution was homogenous. RNA was puriﬁed using the
RNEasy Mini RNA puriﬁcation kit (Qiagen), and RNA was
then transcribed to cDNA using the iScript RT Supermix
(Bio-Rad, Mississauga, Ontario, Canada) according to the
manufacturer’s protocols.

Quantitative Polymerase Chain Reaction
cDNA levels were quantiﬁed using the iTaq Universal
SYBR Green Supermix (Bio-Rad) on a Viia7 real-time polymerase chain reaction system (Thermo Fisher Scientiﬁc).
From 3–4 samples were examined per genotype, at each
time point or condition (see previous sections for details of
tissue collection and RNA puriﬁcation). Primer sequences
were obtained from PrimerBank, and ampliﬁed at w90%
efﬁciency. The primers used are shown in Table 1.

Immunoﬂuorescence and Histochemistry
Following ﬁxation, intestinal tissues were washed in PBS
three times and immersed in 30% sucrose þ PBS overnight at
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4 C to cryoprotect. Tissues were mounted in Tissue-Tek O.C.T
compound (Sakura, Flemingweg, Netherlands) and sectioned
at 10-mm thickness on a cryostat. Slides containing tissue
sections were washed 3 times for 5 minutes at room temperature with PBS. Organoids were stained in 1.5-mL
microcentrifuge tubes following ﬁxation. Samples were
blocked using 5% normal goat serum (Thermo Scientiﬁc,
Toronto, Ontario, Canada) in PBS þ 0.3% Triton-X100
(Fisher, Toronto, Ontario, Canada) for 1 hour. Primary antibody was applied overnight (anti-Villin 1:1000, anti
Lysozyme 1:1000, anti-CCL2 1:75 [Abcam, Toronto, Ontario,
Canada ab130751, ab108508, ab8101, respectively]; antiKi67 1:500 [Vector Labs VP-RM04]; anti-Phospho-HistoneH3 [Ser 10] 1:1000 [Upstate/Millipore, Etobicoke, Ontario,
Canada 06-570]; anti-Per2 1:200 [Millipore AB5428P]; anti–
nuclear factor kB [NFkB] 1:400, anti-Phospho-c-Jun S73
1:800 [Cell Signaling Technology B14E12, D47G9, respectively]; anti-GFP 1:2000 [Nacalai Tesque Inc., Kyoto, Japan
GF090R]; anti-cleaved Caspase3 1:200 [Cell Signaling Technology 9661s] in 1.2% normal goat serum at 4 C overnight.
Sections were washed in PBS 3 times for 5 minutes followed
by incubation in Alexa 488, or Alexa 555 (Life Technologies,
Toronto, Ontario, Canada) secondary antibodies for 1 hour
(1:2000), and counterstained with DAPI or TOPRO3 nuclear
stains (Life Technologies) in 1.2% normal goat serum at room
temperature. Sections were then washed 3 times for 5 minutes in PBS at room temperature and mounted using Prolong Antifade Gold (Invitrogen, Toronto, Ontario, Canada).
Antigen retrieval was performed for CCL2, Lysozyme, NFkB,
and Ki67 using sodium citrate buffer þ 0.5% Tween for 10
minutes at 109 C, 1.7 PSI. Antigen retrieval was performed
for PER2, GFP, and Phospho-c-Jun using 1% sodium dodecyl
sulfate for 10 minutes at room temperature. EdU staining was
done using the Click iT EdU Alexaﬂuor 555 kit according to
manufacturer’s instructions (Thermo Scientiﬁc). Alcian blue
(EMS) staining was done at 30 minutes, room temperature.
The sections were washed under running water for 2 minutes
then immediately rinsed with distilled water. The sections
were then counterstained with Nuclear Fast Red (EMS) for 5
minutes at room temperature. Sections were dehydrated in
95% ethanol 2 times for 5 minutes at room temperature,
followed by another dehydration step with 100% ethanol 2
times for 5 minutes at room temperature. Sections were
cleared using Histo-clear (EMS) 2 times for 10 minutes at
room temperature, and mounted in Clearium (EMS). A total of
3–4 samples were examined per condition (normal conditions versus irradiation, genotype, time point).

Microscopy and Quantiﬁcation
Organoid images were taken using a Keyence BZ9000
microscope. Intestinal tissue sections were imaged using
either a Olympus Fluoview FV-1000 confocal microscope
or a Zeiss LSM780 confocal microscope. Images were
processed using Adobe Photoshop CS5. Antibody-positive
cells were quantiﬁed as the total number of labeled cells/
total number of DAPIþ nuclei present in a crypt section.
Twenty crypts were sampled per animal for the quantiﬁcation of Ki67, phosphorylated histone H3 (pHH3),
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Figure 1. Cell proliferation exhibits a diurnal rhythm during the gastrointestinal syndrome. (A) Crypts exhibit changes
following irradiation (IR), during the gastrointestinal syndrome (4 days after IR). Hematoxylin-eosin staining shows villus
morphology is disrupted, and crypts are less abundant, larger, and hyperplastic. (B) Proliferation and cell death timing over 5
days following IR was assessed in the morning. After injury, proliferation (marked by antiphosphorylated Histone H3 mitoses)
increases, whereas cell death (marked by anticleaved Caspase3 apoptosis) decreases. (C) In the control (nonirradiated) state,
crypt nuclei number is constant (P ¼ .3669). Each data point represents the average of 1 animal (20 crypts sampled). ZT on the
x-axis refers to the time lights turn on (ZT0) and off (ZT12). (D) Following IR, the number of cells increases over 36 hours
between Days 4 and 6 of healing (F ¼ 10.53; P < .0001). This is likely a result of increased proliferation as the epithelium repairs
itself from IR damage. (E) Mitoses in the control (nonirradiated) are constant without signiﬁcant differences over time (P ¼
.2909). (F) During the gastrointestinal syndrome (IR), mitoses exhibit a strong diurnal rhythm with signiﬁcant differences at
different times (F ¼ 11.32; P < .0001). Mitoses peak at approximately ZT0-4 over both days. Each data point represents the
average of 1 animal (20 crypts sampled), and the solid line indicates the average of these.

phosphorylated c-JUN (pJUN), Caspase3, or FUCCI reporters, with 3–4 animals/organoid lines examined per
condition. Paneth cells were quantiﬁed as the number of
lysozyme-positive cells per crypt in 30 crypts sampled
from 3 animals of each genotype. Goblet cells were quantiﬁed as the number of alcian blue–positive cells in 10 villi
ﬁeld of views (20 objective) per animal from 3 animals of
each genotype. Crypts were counted by sampling 10

regions of 1 mm from 6 animals of each genotype. Quantiﬁcation of data shown in Figures 1B, 2A, 3A, and 3C was
done at the time point ZT4.

Statistics
Statistical analysis was carried out using Student’s t test
to compare genotype differences (Figures 1A, 2A, 3A, 3D,
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Figure 2. A BMAL1-dependent diurnal rhythm is present during intestinal regeneration 4–5 days after injury. (A)
Hematoxylin-eosin staining shows both BMAL1þ/þ and BMAL1-/- intestines are adversely affected during the gastrointestinal
syndrome (compare with Figure 1A). The BMAL1-/- epithelium contains signiﬁcantly fewer crypts (P ¼ .0272). (B) Mitosis in the
BMAL1þ/þ and -/- epithelium is marked by pHH3. Images show confocal stacks (merged) from 10-mm sections. (C) Cell
proliferation (marked by Ki67, which labels cells in S/G2/M phases) is present in the irradiated (IR) intestine of both genotypes.
Insets below ﬁrst row of images show higher magniﬁcation of crypts that are proliferating. Images show single confocal
sections of intestinal crypts. (D) The IR BMAL1þ/þ crypt has a diurnal rhythm in mitoses with signiﬁcant differences at different
times (F ¼ 7.30; P ¼ .0002). There are signiﬁcant differences in mitoses between the BMAL1þ/þ and the BMAL1-/- crypt (F ¼
19.07; P ¼ .0002). BMAL1-/- intestinal precursors proliferate arrhythmically and at a lower level overall than BMAL1þ/þ. Bottom
panels show that mitoses vary in both the lower half of crypts (transit-amplifying and stem cell region), and the upper half of
crypts (transit-amplifying cell region). The ﬁrst 24 hours of BMAL1þ/þ data are replotted from Figure 1F. (E) Cell death (marked
by cleaved Caspase3, which labels cells undergoing apoptosis) shows no signiﬁcant time-of-day differences in BMAL1þ/þ
(P ¼ .5046), or differences between BMAL1þ/þ and BMAL1-/- (P ¼ .1072).

and 7C), 1-way analysis of variance to compare differences
in time (Figures 1B–E, 3B, 4A, 4C, 5B, 6A, 6B, and 7B), and 2way analysis of variance to compare difference in both genotype and time (or genotype and expression levels)

(Figures 2D, 3B, 3C, 4A, 4C, 5B, 5D, 6A–C, 7B, 9A, and 9B). All
statistics were done using Prism 5.0 software (Graphpad
Software Inc). Results are indicated in legends; error bars
show standard error of the mean.
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Figure 3. Loss of BMAL1 produces no overt intestinal phenotypes in uninjured mice. (A) At 3 months of age the intestinal
epithelium of BMAL1-/- mice resembles that of BMAL1þ/þ littermates. Hematoxylin-eosin staining shows similar crypt and
villus morphology, although there is a signiﬁcant difference in the number of crypts present (P ¼ .0076). (B) Mitoses in the
BMAL1þ/þ undamaged crypt epithelium show no signiﬁcant diurnal variation (P ¼ .2909), and there are no signiﬁcant differences between BMAL1þ/þ and BMAL1-/- (P ¼ .6842). The ﬁrst 24 hours of BMAL1þ/þ data is replotted from Figure 1E. (C)
Quantiﬁcation of cell type markers by real-time quantitative polymerase chain reaction at ZT4 (n ¼ 4 mice per genotype) shows
no signiﬁcant differences (P ¼ .7412) in the expression of intestinal epithelial genes (CDH1, VIL1, LYZ1), and intestinal epithelial
precursor and stem cell marker genes (OLFM4, LRIG1, ATOH1, LGR5). (D) The BMAL1þ/þ and BMAL1-/- epithelium shows the
same number of goblet cells (alcian blue), enterocytes (VIL), and Paneth cells (LYZ) as shown by the presence of these
cell-type markers. Brightﬁeld images were taken using conventional microscopy, ﬂuorescence images are confocal stacks
(merged) from 10-mm sections taken. The number of Paneth cells, and goblet cells, is not signiﬁcantly different between the 2
genotypes (P ¼ .2528 and P ¼ .7950, respectively).

Organoid Culture
Intestinal organoids were prepared and cultured from intestinal tissues of BMAL1þ/þ, BMAL1-/-, BMAL1þ/þ;FUCCI2þ/-,

BMAL1-/-;FUCCI2þ/-, and PER2-Luciferase mice using established methods.23 For timed RNA collection, and Luciferase
experiments, organoids were passaged and grown for 3–4
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Figure 4. The intestinal epithelium displays a BMAL1-dependent circadian rhythm during normal homeostasis and
during regeneration. (A) The BMAL1þ/þ intestine of animals on a standard 12-hour light/12-hour dark photoperiod shows
rhythms in clock gene expression: PER2 (F ¼ 7.267; P ¼ .0055), BMAL1 (F ¼ 30.67; P < .0001), and REV-ERBa (F ¼ 18.33;
P ¼ .0002). BMAL1-/- animals do not show these rhythms: PER2 (P ¼ .7839), BMAL1 (P ¼ .6397), and REV-ERBa (P ¼ .6880).
Expression of the gene TBP (TATA Binding Protein) has no rhythm in either genotype. There are signiﬁcant differences
between genotypes in PER2 (F ¼ 3.41; P ¼ .0242), BMAL1 (F ¼ 219.0; P < .0001), and REV-ERBa (F ¼ 87.27; P < .0001). (B)
PER2 protein is present in the undamaged intestinal precursors (crypts are outlined to indicate the region where precursors are
located). PER2 is present in higher levels at ZT16–20, and shows nuclear localization in the epithelial cells of the crypt at these
times. At ZT0–8, expression is weaker and predominantly cytoplasmic. Images show single confocal sections of intestinal
crypts. (C) The 24-hour rhythm in clock gene expression 4 days after irradiation is similar to the undamaged intestine, but at
lower levels relative to GAPDH. The gene TBP is not affected by the clock, or stress, and has no circadian rhythm. There are
signiﬁcant differences between genotypes in PER2 (F ¼ 120.8; P < .0001), BMAL1 (F ¼ 225.7; P < .0001), and REV-ERBa
(F ¼ 74.65; P < .0001). IR, irradiation.
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days, then pulsed with 100 nM dexamethasone (Sigma) for 1
hour. Dexamethasone media was then replaced with fresh
media. For RNA sampling, organoids were collected at 4-hour
intervals from 0–28 hours (time is indicated in ﬁgures), by
lysing directly into RLT buffer (Qiagen) with 1% b-mercaptoethanol. Figure 5D organoid RNA was collected from unsynchronized organoids, collected before passaging and
untreated with dexamethasone. Bioluminescence recordings
were performed after dexamethasone treatment, by adding
Luciferin (Gold Biotechnologies) to organoid media at a ﬁnal
concentration of 0.1 mM and monitoring cultures for light
output at 15-minute intervals using a Hamamatsu LM2400
bioluminescence recorder and Hamamatsu LM2400 software
version 12. For tumor necrosis factor (TNF) experiments,
organoids were grown for 6–8 days, then media containing
10 ng/mL recombinant TNF (Life Technologies), or 10 ng/mL
recombinant TNF together with 100 ng/mL function blocking
TNF antibody (R&D Systems, Minneapolis, MN), was applied
for the indicated times (see ﬁgures). Organoids were not
synchronized using dexamethasone in Figures 5D or 7, and
“untreated” are organoids given new media (but with no TNF
or anti-TNF) and collected at 24 hours. For staining and
immunoﬂuorescence, organoids were separated from
Matrigel using Cell Recovery Solution (Corning, Canada) for
30 minutes on ice, and ﬁxed for 1.5 hours in 4% PFA (EMS).
For irradiation experiments (Figure 5E), organoids (unsynchronized/not treated with dexamethasone) were exposed to
X-ray radiation at Day 3 of culture, at 0–8 Gy, then assayed by
CellTiter Glo assay (Promega, Madison, WI) for cell number 4
days later. In all organoid experiments, 3–4 samples were
examined per condition (genotype, and/or time point).

Western Blotting
Organoids were separated from Matrigel by incubating
in Cell Recovery Solution (Corning) on ice for 30 minutes,
supernatant was removed, and samples were lysed in RIPA
buffer containing Pierce Protease and Phosphatase Inhibitor
(Pierce, Toronto, Ontario, Canada). Electrophoresis was
carried out on PAGEr EX Gels (Lonza, Basel, Switzerland)
and Western blotted on PVDF (Thermo Scientiﬁc). Westerns
were blocked 30 minutes with 5% milk in PBS-T 0.1%
Triton X100. Primary antibodies were incubated overnight
at 4 C: anti-Ki67 1:1000 (Abcam ab15580), anti-pJun S73
1:2000 (Cell Signaling Technology D47G9), and antiTubulin 1:5000 (Sigma). Secondary antibodies were incubated for 1 hour at room temperature: Dk anti-Rabbit-HRP
or anti-Mouse-HRP 1:10000 (Jackson ImmunoResearch
711-35-152, 715-035-15, respectively). HRP was developed
using Super Signal Femto (Thermo Scientiﬁc) and imaged
on a FluorChem E Gel Imager (Protein Simple, San Jose, CA).
Three samples were examined for each genotype at all time
points indicated in the ﬁgures.

Cellular and Molecular Gastroenterology and Hepatology Vol. 4, No. 1

epithelium to its original state. Intuitively, this process
would be facilitated if cells were produced as quickly as
possible. To explore the timing of epithelial cell replacement, we investigated the small intestine of mice after highdose (12 Gy) irradiation (Figure 1A). The number of
proliferating cells was assessed using antibody to pHH3,
which labels cells undergoing mitosis, and the number of
dying cells was assessed using antibody to cleaved Caspase3, which labels cells undergoing apoptosis. Immediately
following irradiation, proliferation is very low, then sharply
increases as crypts disintegrate 1 day later (Figure 1B). We
could not distinguish between proliferating epithelial cells
or those from adjacent tissues, such as the blood system,
because 1 day after irradiation the epithelium is highly
morphologically disorganized. However, after this time
epithelial proliferation gradually increases as crypts reappear and grow to regenerate the epithelium. These data are
consistent with previous reports that have shown epithelial
repair occurs several days after damage by irradiation.6,24 In
contrast to proliferation, apoptosis peaks 1 day after irradiation, but then decreases to low levels when crypts are
proliferating (Figure 1B). We focused our investigation on
4–5 days following irradiation, when proliferation is at high
levels and apoptosis is at lower levels.
The regenerating small intestine of mice with the gastrointestinal syndrome was compared with the intestine of unirradiated control animals. Analysis of overall crypt number
showed a marked decrease during the gastrointestinal syndrome compared with control animals (13.3 ± 0.7 crypts per
mm vs 23.2 ± 0.9 crypts per mm; Student’s t test; P < .0001),
presumably caused by extensive cell death from radiation.5
However, unlike crypts in undamaged intestines whose cell
number remains constant over the course of 24 hours
(Figure 1C), the surviving crypts during the gastrointestinal
syndrome are hyperplastic (Figure 1D), suggesting an
increased rate of proliferation in response to damage.
To assess the mitotic index, we quantiﬁed the percentage of
pHH3-positive nuclei relative to the total number of crypt
nuclei present. During the gastrointestinal syndrome, the intestine shows a higher mitotic incidence than in control mice
(Figures 1E and F), conﬁrming the tissue is undergoing rapid
regeneration. The nonirradiated intestine shows 2% mitotic
cells in crypts over the course of 24 hours. Strikingly, the rate of
mitoses during the gastrointestinal syndrome demonstrates a
diurnal rhythm: the mitotic index at its peak is 5%–7% (ZT4)
and at its lowest is 2%–3% (ZT12). This diurnal pattern of
peaks and troughs repeats itself with a 24-hour period
(Figure 1F), and mitoses are present in the upper and lower
regions of the crypt suggesting that circadian regulation occurs
in the stem cell and transit-amplifying cell populations. These
results are consistent with studies published >40 years ago
reporting daily variability in intestinal cell proliferation,25,26 but
which are now overlooked in studies of intestinal regeneration.

Results
Timing of Cell Death and Proliferation During the
Gastrointestinal Syndrome

BMAL1 Is Required for Diurnal Proliferation
Rhythms During the Gastrointestinal Syndrome

When intestinal cells are damaged and die, stem and
precursor cells divide to replace cells and return the

The circadian clock functions in nearly all cells of the
body, including the stomach,15 intestine,14 and colon.13,15 In
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Figure 5. The intestinal epithelium has a clock. (A) Intestinal organoids were established from both BMAL1þ/þ and -/- intestines.
Phase-contrast images are shown in brightﬁeld. (B) BMAL1þ/þ organoids show circadian rhythms in clock gene expression: PER2 (F ¼
46.41; P < .0001), BMAL1 (F ¼ 38.41; P < .0001), REV-ERBa (F ¼ 46.10; P < .0001), and CRY1 (F ¼ 15.96; P ¼ .0009). The control gene
TBP does not show such rhythms but rather a gradual decrease following dexamethasone synchronization. There are signiﬁcant differences between genotypes in PER2 (F ¼ 5.21; P ¼ .0387), BMAL1 (F ¼ 866.6; P < .0001), REV-ERBa (F ¼ 556.8; P < .0001), and CRY1
(F ¼ 32.17; P < .0001). (C) Organoids were established from 3 separate PER2-Luc intestines and luminescence readings show that
rhythms in transcriptional clock activity persist for several days (1 representative tracing is shown). (D) Cellular markers in unsynchronized
organoids quantiﬁed by real-time quantitative polymerase chain reaction show that BMAL1-/- intestinal organoids have decreased
expression of CDH1 (P ¼ .0148), VIL1 (P ¼ .0223), LYZ1 (P ¼ .0498), and LGR5 (P ¼ .0149) expression. (E) The number of viable organoid
cells (CellTiter Glo assay) is equivalent between BMAL1þ/þ and BMAL1-/- organoids, 4 days after varying doses of X-ray irradiation (as
indicated in the graph). The intestinal epithelium has no signiﬁcant BMAL1-dependent differences in sensitivity to radiation (P ¼ .5310).
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Figure 6. The regenerative response inﬂuences the 24-hour rhythms of genes. (A) WEE1 shows diurnal variability in the
undamaged intestine, with signiﬁcant differences between BMAL1þ/þ and BMAL1-/- (F ¼ 8.04; P ¼ .0005). CCND1 and CCL2
expression are similar in both genotypes, whereas TNF exhibits 24-hour variability in the undamaged BMAL1þ/þ intestine, but
none in the BMAL1-/- (F ¼ 15.99; P ¼ .0008). (B) During the gastrointestinal syndrome (IR), WEE1 is arrhythmic (P ¼ .7382),
but CCND1 displays high and low periods of expression over 24 hours. These are not likely a function of the circadian clock,
but rather a response to environmental changes (eg, feeding), because the BMAL1-/- mutant also shows the same pattern,
albeit at a signiﬁcantly lower level (F ¼ 16.04; P ¼ .0006). CCL2 exhibits a BMAL1-dependent circadian rhythm (F ¼ 4.318;
P ¼ .0176), as does TNF (F ¼ 4.204; P ¼ .0221). There are signiﬁcant differences between genotypes in CCL2 (F ¼ 7.13; P ¼
.0137) and TNF (F ¼ 7.66; P ¼ .0109). Increased levels of TNF are present in BMAL1-/- mice at ZT4, whose levels are otherwise
lower at all times compared with BMAL1þ/þ. It is only at this time point that expression is elevated, suggesting that TNF
production in the absence of BMAL1 may be a response to an environmental cue (eg, feeding). (C) BMAL1þ/þ organoids show
no rhythms in WEE1 or CCL2 expression (compare with the control gene TBP in Figure 5B); however, TNF is expressed with a
24-hour rhythm in BMAL1þ/þ but not BMAL1-/- organoids (F ¼ 10.45; P ¼ .0060). This suggests that only TNF is regulated by
the clock in intestinal epithelial cells. IR, irradiation.

these gastrointestinal tissues, the clock has been proposed
to play a key role in digestion and homeostasis7,16; however,
its role in intestinal regeneration has not been studied
genetically in mammals. We therefore investigated the core
clock gene, BMAL1, using BMAL1-/- mutant mice that are
viable but have a complete loss of circadian clock function.9
BMAL1-/- mice have been shown to display signs of premature ageing, hence we performed all of our studies using
mice at 12–15 weeks of age before ageing and other

health-related phenotypes have been observed.27 BMAL1þ/þ
and BMAL1-/- littermate mice were housed on a 12-hour
light/12-hour dark photoperiod to test the role of BMAL1
in regeneration.
During the gastrointestinal syndrome both BMAL1þ/þ
and BMAL1-/- intestines lose their characteristic
morphology, and BMAL1-/- crypts show a w10% decrease
in abundance relative to BMAL1þ/þ (Figure 2A). Regenerating crypts of both genotypes are highly proliferative, as
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Figure 7. The circadian
clock regulates JNK
signaling. (A) CCL2 chemokine is expressed heterogenously in epithelial
cells including LYZþ Paneth cells (arrows in top row
of images), and crypt precursors (epithelial cells
within crypt shown in middle row of images), as well
as blood cells that are
likely monocytes or macrophages that, like Paneth
cells, all coexpress LYZ
(cells outside of crypts
denoted by arrowheads).
Images show confocal
stacks (merged) from 10mm sections taken at ZT4
(crypts are outlined). (B)
The NFkB transcription
factor does not show signiﬁcant nuclear accumulation at any time point over
24 hours (ZT8 is shown as
an example), in either genotype, suggesting it is not
regulated by the circadian
clock. (C) pJUN shown by
its nuclear localization (arrows) is higher in BMAL1þ/
þ
crypts at ZT16–20 during
the gastrointestinal syndrome. Although pJUN
shows variability between
crypts and within crypt
cells, overall the BMAL1-/intestine shows less activity at all times. Images
show confocal stacks
(merged) from 10-mm sections. Quantiﬁcation of the
percentage of pJUNþ crypt
cells is indicated in the individual panels.

marked by the presence of antibody to pHH3, which labels
cells in M-phase (Figure 2B), and Ki67, which labels cells in
G1/S/G2/M-phases (Figure 2C). In contrast to the
BMAL1þ/þ regenerating intestine, the mitotic index in the
regenerating BMAL1-/- intestine does not show a diurnal
rhythm (Figure 2D). Signiﬁcant differences in mitosis are
present between the BMAL1þ/þ and BMAL1-/- intestine,
with the latter showing a lower mitotic index and
arrhythmic cell production. However, unlike these proliferation differences, apoptosis is equivalent between the 2
genotypes and is not rhythmic (Figure 2E). These data
show that diurnal, BMAL1-dependent changes in proliferation occur in the epithelium during the gastrointestinal
syndrome, and that the loss of BMAL1 causes a small
decrease in overall crypt number.

BMAL1 Is Not Required During Intestinal Tissue
Maintenance in Uninjured Mice
We next tested whether intestinal cell production is
BMAL1-dependent under normal, undamaged conditions.
The loss of BMAL1 produced no obvious differences in intestinal crypt or villus morphology; however, a slight but
signiﬁcant decline in the number of crypts was noted
(Figure 3A). This result is consistent with recent ﬁndings
that the PER1/PER2 double mutant also has a slight
decrease in crypt number.28 The BMAL1-related difference
in baseline crypt number may explain the overall reduction
in the number of crypts following irradiation (Figure 2A).
In the absence of radiation damage, we found no signiﬁcant diurnal variation in mitoses in the BMAL1þ/þ intestine,
and no signiﬁcant differences between BMAL1þ/þ and
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Figure 8. The circadian clock regulates proliferation timing in the intestinal epithelium. (A) Representative Western blots
from 3 organoid lines examined per genotype (outer black lines indicate separate blots). BMAL1þ/þ intestinal organoids show a
JNK signaling response to TNF at 0.5 hours (pJUN), which is absent when organoids are treated with anti-TNF inhibitor. TNF
treated BMAL1þ/þ organoids are proliferative (Ki67), but this is also reduced by anti-TNF. BMAL1-/- organoids show a JNK
(pJUN) response to TNF, but their proliferation (Ki67) is initially very high compared with BMAL1þ/þ. (B) BMAL1þ/þ organoids
exhibit a TNF-dependent upregulation of P21 expression (F ¼ 36.85; P ¼ .0007), with an initial increase at 4 hours followed by
a sharp decrease at 8 hours (Tukey multiple comparisons test shown). BMAL1-/- do not show this pattern, and anti-TNF
treatment of BMAL1þ/þ organoids results in an increase rather than decrease in P21 expression over time. There are
signiﬁcant differences in P21 between these genotypes/conditions (F ¼ 4.061; P ¼ .0033). Expression of the JUN target gene,
CCND1, is signiﬁcantly lowered by anti-TNF in BMAL1þ/þ organoids over time (F ¼ 9.865; P ¼ .0017) but does not vary
signiﬁcantly between BMAL1þ/þ and BMAL1-/- organoids (P ¼ .6678). (C) S-phase (marked by EdU uptake) is higher in
BMAL1-/- organoids 4 hours after TNF treatment, consistent with their lower level of P21 at this time (Student’s t test
comparison is shown). Untreated organoids (media change only) show no such differences (P ¼ .7811). (D) The FUCCI cell
cycle reporter shows that BMAL1þ/þ organoids have greater numbers of crypt cells in G1-phase compared with BMAL1-/organoids, 4 hours after TNF induction. Pie charts show the percentage of crypt cells in each phase, in the corresponding
genotypes; there are signiﬁcantly more G1 cells in BMAL1þ/þ compared with BMAL1-/- (Student’s t test, P ¼ .0020).
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Figure 9. Equivalent gene
expression
in
intestinal
organoid
culture.
(A)
BMAL1þ/þ, BMAL1-/-, and
BMAL1þ/þ organoids treated
with anti-TNF show similar
expression of the JNK target
gene CD44 (P ¼ .8363). (B)
BMAL1-/- organoids show
similar expression of the cell
cycle regulators CCNB1 (P ¼
.5970), CCNE1 (P ¼ .4307), CMYC (P ¼ .7082), and E2F
(P ¼ .8220) when stimulated
with TNF.

BMAL1-/- (Figure 3B). The absence of such rhythms in
maintenance conditions is consistent with studies that reported no daily variation in intestinal cell production,29,30
predating subsequent studies that reported a circadian
rhythm.25,26
To assess the impact of BMAL1 loss on cell lineage
development, intestine cell-speciﬁc markers were examined
via quantitative real-time polymerase chain reaction
between BMAL1þ/þ and BMAL1-/- mice. No signiﬁcant differences in expression levels between the genotypes was
found, suggesting that the epithelial cell lineage is intact
when BMAL1-/- is absent (Figure 3C). However, we did note
that LGR5 and OLFM4, both markers of a crypt base stem
cell population,1 are slightly lower in BMAL1-/-. No obvious
differences in morphology or distribution in goblet cells,
enterocytes, or Paneth cells were noted (Figure 3D), suggesting that the production of differentiated cells in the
BMAL1-/- intestine is unaffected under baseline conditions.
We further quantiﬁed Paneth cells and goblet cell numbers,
and conﬁrmed there were no signiﬁcant differences between the BMAL1þ/þ and BMAL1-/- intestine (Figure 3D).

We conclude that under maintenance conditions, the loss of
BMAL1 does not disrupt intestinal epithelial tissue renewal.

Circadian Clock Activity Persists During Stress
The intestine has been reported to exhibit 24-hour
rhythms in clock gene expression,14 hence we investigated
the expression of circadian clock genes in the intestine of
BMAL1þ/þ and BMAL1-/- littermate mice. Consistent with
previous reports,13–16,31 the undamaged intestine of
BMAL1þ/þ mice exhibits a diurnal expression pattern of
PER2, BMAL1, and REV-ERBa (Figure 4A). The sinusoidal,
rhythmic expression proﬁles are consistent with rhythms
seen in other mouse tissues, with BMAL1 expression
peaking at ZT20, approximately antiphase to the time of
peaks of PER2 (ZT8-12) and REV-ERBa (ZT8).32 The
BMAL1-/- intestine shows no rhythms in the expression of
these genes under the same conditions, conﬁrming the
clock is dysfunctional when BMAL1 is absent. The gene TBP,
which is not clock-regulated,33 shows no rhythms in either
genotype under LD photoperiod.
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Table 1.List of Primer Sequences
Target

Forward primer

Reverse primer

ATOH1

GAGTGGGCTGAGGTAAAAGAGT

GGTCGGTGCTATCCAGGAG

BMAL1

TGACCCTCATGGAAGGTTAGAA

GGACATTGCATTGCATGTTGG

CCL2

TTAAAAACCTGGATCGGAACCAA

GCATTAGCTTCAGATTTACGGGT

CCND1

GCGTACCCTGACACCAATCTC

CTCCTCTTCGCACTTCTGCTC

CCNE1

GTGGCTCCGACCTTTCAGTC

CACAGTCTTGTCAATCTTGGCA

CD133

CCTTGTGGTTCTTACGTTTGTTG

CGTTGACGACATTCTCAAGCTG

CD44

TCGATTTGAATGTAACCTGCCG

CAGTCCGGGAGATACTGTAGC

CDH1

TCGGAAGACTCCCGATTCAAA

CGGACGAGGAAACTGGTCTC

C-MYC

ATGCCCCTCAACGTGAACTTC

GTCGCAGATGAAATAGGGCTG

CRY1

CACTGGTTCCGAAAGGGACTC

CTGAAGCAAAAATCGCCACCT

E2F

GAGAAGTCACGCTATGAAACCTC

CCCAGTTCAGGTCAACGACAC

GAPDH

AGGTCGGTGTGAACGGATTTG

TGTAGACCATGTAGTTGAGGTCA

LGR5

CCTACTCGAAGACTTACCCAGT

GCATTGGGGTGAATGATAGCA

LRIG1

TTGAGGACTTGACGAATCTGC

CTTGTTGTGCTGCAAAAAGAGAG

LYZ1

GAGACCGAAGCACCGACTATG

CGGTTTTGACATTGTGTTCGC

OLFM4

CAGCCACTTTCCAATTTCACTG

GCTGGACATACTCCTTCACCTTA

P21

CCTGGTGATGTCCGACCTG

CCATGAGCGCATCGCAATC

PER2

GAAAGCTGTCACCACCATAGAA

AACTCGCACTTCCTTTTCAGG

REV-ERBa

TGAACGCAGGAGGTGTGATTG

GAGGACTGGAAGCTATTCTCAGA

TBP

AGAACAATCCAGACTAGCAGCA

GGGAACTTCACATCACAGCTC

TNF

CCCTCACACTCAGATCATCTTCT

GCTACGACGTGGGCTACAG

VIL1

TCAAAGGCTCTCTCAACATCAC

AGCAGTCACCATCGAAGAAGC

WEE1

GAAACAAGACCTGCCAAAAGAA

GCATCCATCTAACCTCTTCACAC

We next examined PER2 protein in intestinal crypts by
immunoﬂuorescence over a 24-hour time span (Figure 4B).
PER2 protein is rhythmically expressed under circadian
clock regulation, in many tissues, with a peak abundance
that typically lags behind maximal transcript levels by 4–6
hours.34 In the intestine, PER2 is expressed at higher levels
during the night (ZT16-20), in the crypts where proliferating intestinal stem cells and transit-amplifying cells reside.
To assess if the circadian clock continues to function
during the pathologic state of the gastrointestinal syndrome,
we tested the expression of BMAL1, PER2, and REV-ERBa
transcripts. These clock genes exhibit diurnal rhythms in
BMAL1þ/þ mice that peak at times similar to the undamaged
intestine, but are reduced in levels relative to GAPDH
(Figure 4C). Thus, the circadian clock is intact during the
intestinal regenerative response, and shows similar activity
timing as during normal conditions (Figure 4A). These data
suggest that the gastrointestinal syndrome does not reset
the phase of the intestinal clock.

Circadian Clock Regulates Intestinal Organoid
Gene Expression
The intestine contains epithelium, muscle, nerves, blood
cells, and connective tissues, and the clock transcripts
detected in our samples (Figures 3C, 4A, and 4C) may be
expressed by any of these cells. Previous circadian studies
have relied on similar sampling methods,15,16 or have
enriched for differentiated epithelial cells by scraping them

from the surrounding tissues.13,14 Although scraping
enriches for epithelial genes, samples may contain nonepithelial cell RNA. To speciﬁcally assess the circadian
clock in the intestinal epithelium, we established pure
epithelial cell cultures using intestinal stem cells from
BMAL1þ/þ and BMAL1-/- mice to generate organoids
(Figure 5A).23
Organoids were treated with a 1-hour pulse of dexamethasone to synchronize their clocks,33 resulting in rhythmic expression of the clock genes BMAL1, PER2, CRY1, and
REV-ERBa (Figure 5B). BMAL1þ/þ intestinal organoids show
clock gene expression patterns (Figure 5B) that strongly
resemble those in vivo (Figure 4), whereas BMAL1-/- do not,
suggesting that the intestinal epithelium contains a functional
circadian system that requires BMAL1. The control gene TBP
is not rhythmic in organoids, and displays a gradual decrease
in expression over this time. We further conﬁrmed that intestinal organoids express tissue-autonomous circadian
rhythms by examining bioluminescence rhythms in organoids
derived from PER2-Luciferase mice.35 Per2-Luciferase organoids show circadian rhythms that persist for >4 days
following synchronization (Figure 5C). These results are
consistent with recent reports using organoid culture,28,36
which support that the intestinal epithelium has a tissueautonomous, BMAL1-dependent circadian clock.
We next reexamined the expression of cell-speciﬁc
markers to test the consequence of BMAL1 loss in organoid culture. We examined organoids before dexamethasone
synchronization, and compared BMAL1þ/þ and BMAL1-/- at
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1 time point (Figure 5D). Quantitative real-time polymerase
chain reaction showed that BMAL1-/- organoids have lower
expression of the differentiated genes CDH1, VIL1, and LYZ1,
as well as LGR5, a marker of intestinal precursor and stem
cells. These deﬁciencies suggest that the production or
function of epithelial cells is autonomously reduced in the
intestinal epithelium, when BMAL1 is absent. To further test
cell production in organoids, we examined cell number in
organoids in normal conditions, and 4 days following
exposure to 1, 4, or 8 Gy X-irradiation. There were no signiﬁcant BMAL1-dependent differences in organoid cell
number assayed following irradiation damage (Figure 5E).
Our results are consistent with previous ﬁndings that the
circadian clock does not regulate cell survival in vitro
following irradiation.37

Cell Cycle Regulators Are Arrhythmic
During Regeneration
Cell division often exhibits a 24-hour cycle but how or
whether it is linked to the circadian clock is a matter of longstanding research.10 Two cell cycle regulators, WEE1 and
CCND1, have been previously implicated as clock targets,38,39 and we therefore hypothesized that these might
drive rhythms in cell proliferation during the gastrointestinal syndrome.
WEE1 is a direct CLK/BMAL1 target in the liver, where it
represses the G2-M phase transition.38 In the undamaged
BMAL1þ/þ intestine, WEE1 expression has a diurnal rhythm
(peak is ZT8-12), consistent with previous reports,14 and its
expression in BMAL1-/- animals is arrhythmic, suggesting
clock control (Figure 6A). However, at this time point
mitoses are not actually rhythmic (Figure 3B). During the
gastrointestinal syndrome, WEE1 expression is arrhythmic
(Figure 6B), despite the strong diurnal rhythm in mitosis
present (Figure 2D). This suggests WEE1 rhythms are
decoupled from proliferation rhythms in this tissue, hence,
we further tested whether the intestinal epithelial clock
regulates WEE1 autonomously using organoid culture.
Despite possessing circadian clock activity (Figures 5B and
C), BMAL1þ/þ organoids do not exhibit rhythms in WEE1
gene expression (Figure 6C).
CCND1 (CyclinD) is regulated by CLK/BMAL1 in
osteoblasts, where it enables the G1-S phase transition.40
CCND1 is arrhythmic in both the BMAL1þ/þ and BMAL1-/intestine under normal conditions (Figure 6A), but exhibits
24-hour variation during the gastrointestinal syndrome
(Figure 6B). This daily pattern of CCND1 expression is similar
in both the BMAL1þ/þ and BMAL1-/- intestine, suggesting it is
not regulated by the circadian clock. Taken together, these
data suggest that neither WEE1 nor CCND1 link the clock and
the cell cycle in the intestinal epithelium. We therefore sought
to investigate other mechanisms that could shed light on how
the epithelium proliferates with a circadian rhythm.

Cytokine Production Is Rhythmic
During Regeneration
The immune system has circadian rhythms41,42 as
evidenced by its highly variable time-of-day-dependent
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response to infection,43,44 its susceptibility to photoperiod
and
clock
regulation
of
cytokine
disruption,45
production.42–44 Inﬂammation is likely to affect intestinal
physiology during the gastrointestinal syndrome, and
recently it has been shown that the innate immune system
coordinates circadian rhythms between the microbiota and
the intestinal epithelium.46 We therefore examined whether
inﬂammation during the gastrointestinal syndrome regulates intestinal cell production. The immune system produces many factors whose rhythmic expression could drive
circadian processes in the epithelium. We tested the
expression of several cytokines (TNF, IL6, IL10, IL17B, IL22,
and CCL2), some of which have been previously implicated
in the circadian biology of the immune system.41–43
CCL2, a chemokine that recruits monocytes to regions of
infection and injury, is not expressed with diurnal variation
in the undamaged intestine (Figure 6A), but shows diurnal
changes during the gastrointestinal syndrome in BMAL1þ/þ
but not in BMAL1-/- (Figure 6B). The TNF cytokine displays
diurnal variation in BMAL1þ/þ intestines during normal
conditions, and is arrhythmic and lower in BMAL1-/(Figure 6A). During the gastrointestinal syndrome, the
BMAL1þ/þ intestine exhibits diurnal changes in TNF. These
are altered in BMAL1-/- animals, which show a single sharp
peak at ZT4, but otherwise remain lower than BMAL1þ/þ at
all other times (Figure 6B). These results suggest that TNF
and CCL2 exhibit clock-dependent expression during the
gastrointestinal syndrome. The interleukin genes we
examined (IL6, IL10, IL17B, and IL22) did not show any
diurnal BMAL1-dependent changes under the 2 conditions
examined.
We tested whether TNF and CCL2 are produced by the
intestinal epithelium. TNF is known to be expressed in
intestinal epithelial cells,47 and BMAL1þ/þ organoids exhibit
24-hour rhythms in TNF that are absent in BMAL1-/- organoids, suggesting it is a clock target in the epithelium
(Figure 6C). CCL2 is not expressed with a rhythm in organoid culture (Figure 6C), suggesting its rhythmic expression
in vivo is not caused by the epithelium. This was further
tested by antibody staining in irradiated animals, where
CCL2 was expressed by cells that stained positively for the
marker LYZ, suggesting these were monocytes or macrophages (Figure 7A). CCL2 was also expressed in the
epithelium at ZT4 in both epithelial precursors and Paneth
cells where it is has been shown to be induced by TNF.48
These results suggest that CCL2 is produced by both the
epithelium and resident white blood cells, but that epithelial
cells are not responsible for CCL2 diurnal rhythms during
the gastrointestinal syndrome.

BMAL1 Regulates the Tumor Necrosis
Factor Response
TNF is an inﬂammatory cytokine, which can signal
through both NFkB and c-JUN transcription factors.49 These
pathways have been recently implicated in intestinal proliferation: sustained activity of NFkB50 or JNK51 leads to
hyperplasia and tumorigenesis. We tested the activity of the
TNF pathway by staining for NFkB and pJUN over a 24-hour
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time course, 4 days following radiation injury. NFkB is
predominantly cytoplasmic in the crypt cells of both
BMAL1þ/þ and BMAL1-/- mice, suggesting that NFkB is not
active under these conditions (Figure 7B). In contrast, pJUN
has a higher nuclear signal in the proliferating crypts of
BMAL1þ/þ mice at ZT16, during the gastrointestinal syndrome, but is lower at other times (Figure 7C). BMAL1-/crypts show lower signal and no diurnal variation over 24
hours. This suggests JNK signaling is regulated by the
circadian clock during the gastrointestinal syndrome, either
through rhythmic production of TNF by the surrounding
myeloid cells42 or from epithelial cells themselves
(Figure 6C).
Signaling between intestinal epithelial and nonepithelial
cells is a very complex dynamic. Hence we tested whether
BMAL1 regulates the epithelial response to TNF using intestinal organoids, which contain only epithelial cells. Both
BMAL1þ/þ and BMAL1-/- organoids have an immediate
response to TNF, which causes an increase in pJUN levels
0.5 hours after stimulation (Figure 8A). Function-blocking
anti-TNF antibody completely abolishes the pJUN response
in BMAL1þ/þ organoids conﬁrming this is a TNF-dependent
process. We next examined a possible link between TNF
signaling and proliferation. BMAL1þ/þ organoids are proliferative (Ki67 positive) before and after TNF-stimulation,
suggesting TNF does not reduce epithelial proliferation
during inﬂammation. In contrast, Ki67 is initially much
higher in BMAL1-/- organoids and decreases 4 hours after
TNF exposure. Function-blocking anti-TNF antibody reduces
Ki67 expression, showing that TNF promotes proliferation
in the epithelium. Together, these data show that BMAL1
regulates cell proliferation downstream of TNF, but the JNK
pathway is BMAL1-independent.
JUN target genes, in particular cell cycle and cell growth
regulators, were examined during TNF activation. BMAL1-/organoids have equivalent expression of the JUN target
genes CCND1 and CD44, but show differences in the regulation of P21 (also called CDKN1A), a negative regulator of
proliferation (Figures 8B and 9A). Speciﬁcally, BMAL1þ/þ
organoids exhibit a TNF-dependent upregulation of P21
expression 4 hours after induction followed by a sharp
decrease at 8 hours. This response is completely absent in
BMAL1-/- organoids, which simply show a gradual decrease
in P21 expression. This suggests the timing of cell cycle
entry, during an inﬂammatory response, is altered when
BMAL1 is absent. However, the altered expression of cell
cycle regulators is not a general feature of BMAL1-/- organoids, because these show equivalent expression of CCNB1,
CCNE1, E2F, and C-MYC (Figure 9B). We hypothesized that 1
function of BMAL1 is to produce a w4-hour delay in cell
cycle entry during the regenerative response to TNF.
To test this hypothesis, we assessed the number of
epithelial cells undergoing S-phase using EdU labeling in
BMAL1þ/þ versus BMAL1-/- organoids following TNF treatment. BMAL1þ/þ organoids, whose P21 levels are higher,
show reduced S-phase entry compared with BMAL1-/organoids, whose levels of P21 are lower at this time
(Figure 8C). To further assess the impact of TNF on cell
cycle dynamics, we crossed the FUCCI2 cell cycle reporter
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strain,52 which marks cells in G1 (RFP) and S/G2/M (GFP),
on the BMAL1 background. We generated organoids from
the BMAL1þ/þ, FUCCI2þ/- versus BMAL1-/-, FUCCI2þ/- mice
and tested their response to TNF treatment. Consistent with
their increase in S-phase entry, BMAL1-/- organoid cells
show a decrease in G1 phase compared with BMAL1þ/þ
control animals (Figure 8D). These data show that 1 function of BMAL1 is to regulate the timing of cell proliferation
in response to inﬂammatory stress. Not only does the clock
regulate TNF expression itself (Figures 6A–C), but in
response to TNF, the circadian clock regulates the timing of
epithelial S-phase.

Discussion
We ﬁnd that the circadian clock is active in the intestinal
epithelium during normal and pathologic states. However,
these distinct physiological states exhibit differences in
circadian gene expression. Epithelial regeneration during
the gastrointestinal syndrome shows circadian rhythms in
proliferation, and cytokines and cell cycle regulators are
regulated by the core clock gene BMAL1. These outputs are
not present in the undamaged state, suggesting this program is dynamically initiated during regeneration. Based on
these data, we propose a model of circadian clock function
in the small intestine in which the targets TNF and P21
cooperate to drive diurnal rhythms in cell production
(Figure 10).

Circadian Proliferation in the Intestinal Epithelium
The intestine has been reported to exhibit circadian
rhythms in its physiology, including 24-hour rhythms in
proliferation.7,25,26 However, we found no signiﬁcant
diurnal changes in mitosis under normal homeostatic conditions in this tissue (Figure 1E). Similarly, early attempts to
ﬁnd circadian rhythms in the small intestine were also unsuccessful.29,30,53 There are several possibilities to account
for these discrepancies. Previous studies that reported
circadian rhythms in mitoses25 may have sampled different
regions of the small intestine, which exhibit regional differences in circadian clock activity.14 For instance, such
regions as the duodenum show very slight diurnal changes
in S-phase versus such regions as the ileum that show highamplitude changes.7 It is possible the regions we sampled
(ie, the duodenum and proximal jejunum) do not show highamplitude 24-hour changes under undamaged conditions.
Another possibility is that speciﬁc phases of the cell cycle
might be differentially regulated by the clock, or other factors, such as diet and/or microbiota, could also affect the
expression of intestinal rhythmicity.
Despite the absence of mitotic rhythms during normal
conditions, we ﬁnd strong diurnal variation in mitosis
during the regenerative response following irradiation
(Figure 1F). Because studies supporting7,25,26 and
refuting29,30,53 circadian rhythmicity in intestinal cell proliferation have been published, it is also possible that an
additional factor contributes to these rhythms. Reports of
circadian rhythms in the digestive tract applied tritiated
thymidine to label cells undergoing S-phase.25,26 These
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the clock are either not directly linked, or can be decoupled.
Our results support that the circadian clock controls the cell
cycle regulator P21, during the inﬂammatory response to
TNF. Twenty-four-hour rhythms in the expression of P21
have been observed in cancer patient colon biopsies
suggesting this ﬁnding may be conserved in mammals.55
In addition to these connections, we cannot discount
circadian control of the cell cycle through transcriptional or
posttranscriptional regulation of different genes involved in
proliferation. Genome-wide transcriptome and proteome
analysis of all cell cycle regulators in this tissue would
resolve this question, and the precise targeting of cell cycle
regulators by the circadian clock in the intestinal
epithelium.

Circadian Control of Cell Signaling

Figure 10. A proposed model of circadian clock function
in the regenerating small intestinal epithelium. BMAL1
controls TNF and P21 during a pathologic state. TNF cytokine
signaling increases epithelial proliferation in epithelial precursors to replace damaged epithelial cells. Rhythms in TNF
production may arise from the epithelium but also are well
known to be rhythmically produced by the immune system
(see discussion). In epithelial cells, P21 response is under
clock control downstream of TNF to regulate diurnal rhythms
in cell production.

experiments involved injecting animals over a 24-hour
timeline and collecting samples 1 hour after injection. To
avoid an injection-related stress response, we assayed the
cell cycle noninvasively by detecting M-phase using antibody to pHH3, and detected diurnal rhythms in cell production during a pathologic state. We have previously
shown that proliferation in the Drosophila intestine is gated
by the circadian clock only during regeneration, and that
before damage no rhythms are detected.54 This bears a
similarity to our present results, and we thus suggest
physiological stresses drive and/or amplify circadian
rhythms in cell proliferation.

Circadian Control of the Cell Cycle
There is compelling evidence to link the cell cycle with
the circadian clock,10 and regulators, such as WEE1, have
been shown to be bona ﬁde clock targets in the liver.38 A
direct link between cell cycle regulation and the circadian
clock has yet to be established in the intestinal epithelium. A
recent study has shown that cell proliferation rhythms in
the colon can be changed by altering the timing of food
intake,31 suggesting the clock may not control the cell cycle
in intestinal epithelia directly. We ﬁnd that WEE1 is
arrhythmic during healing (Figure 6B), when proliferation is
rhythmic (Figure 2D), demonstrating that the cell cycle and

Genes involved in the immune response, such as TNF
and CCL2, exhibit diurnal rhythms during healing. In
particular, the TNF inﬂammatory cytokine exhibits diurnal
changes in the intestine (Figures 6A and B) and is rhythmically expressed in organoid epithelia autonomously
(Figure 6C). TNF production has been shown to exhibit
circadian rhythms in a variety of tissues,42,43 and it is very
likely to be produced by the epithelium and its surrounding
cells. A recent study showed that the regulation of TNF
expression in the colon is disrupted in clock mutants
exposed to alcohol-induced injury.56 This suggests the role
of the clock in the regulation of these genes may be a general feature in digestive tract pathology. Further work is
needed to resolve the complex interplay between clockregulated sources of the different cytokines that regulate
the digestive system.
Similar to our previous studies in Drosophila,54 proliferation rhythms during regeneration involve signaling processes. Overall, our results suggest that as epithelial cells
switch from a state of tissue maintenance to a state of
regeneration, the circadian clock regulates different target
genes. Such a process may involve the recruitment of transcriptional regulators to work in conjunction with the genes
CLK and BMAL1, REV-ERBa, or RORa in the same cell.
Alternatively, context-dependent posttranscriptional mechanisms11,57 may alter transcriptional output in these cells
during regeneration.
The effect of cytokines on epithelial cell production is
particularly relevant in understanding how disease states,
such as inﬂammation and cancer, are related.58 TNF is of
particular importance and, consistent with our results, has
been recently reported to increase the proliferation of
intestinal organoids.59 TNF can activate both NFkB50 and
JNK51,60 pathways, both of which promote proliferation
and tumorigenesis of intestinal epithelia. We ﬁnd that TNF
is produced rhythmically by the intestinal epithelium
under clock control, and that the clock further regulates
the proliferation response to TNF. The DNA-binding activity of JUN has been observed to be circadian,46 consistent
with these ﬁndings. Our results showing the circadian clock
regulation of P21 are consistent with observations in the
circadian expression of P21 in human55 and zebraﬁsh61
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cells, overall suggesting a conserved mechanism of cell
cycle control.
JNK signaling can enhance Wnt pathway activity in the
intestinal epithelium,51 and cJUN has also been shown to be
enriched in the LGR5þ intestinal stem cell population.62 NFkB
activation also enhances Wnt signaling and causes the
dedifferentiation of transit-amplifying cells into intestinal
stem cells.63 The rhythmic production of TNF in the epithelium during the gastrointestinal syndrome could therefore
inﬂuence stem cell and transit-amplifying cells by boosting
Wnt signaling. Similar circadian clock activity in stem cells
has been documented in several systems.64 In intestinal
organoids, we ﬁnd that the BMAL1-/- epithelium shows deﬁciencies in the expression of epithelial markers (Figure 5D).
In particular, a reduction in LYZ1 and LGR5 expression in
organoids may explain why the BMAL1-/- intestine shows a
slight reduction in crypt number (Figures 2A and 3A) and
LGR5 expression (Figure 3C) in vivo. LGR5þ intestinal stem
cells are intermingled with Paneth cells in a Wnt signaling
milieu, and a reduction in stem cell and Paneth cell markers
suggests a maintenance deﬁciency. Although these phenotypes seem to be generally compensated during maintenance
in vivo (Figure 3) and in vitro (Figure 5E), the circadian clock
may play a role in epithelial Wnt signaling in certain physiological contexts. While this study was under revision, it was
reported that Wnt signaling is regulated by the clock in intestinal organoids, caused by the expression of WNT3A by
Paneth cells.28 Circadian control of intestinal signaling pathways may be an important mechanism linking tissue homeostasis with general physiology.

Circadian Rhythms in Disease
The health of shift-workers who undergo photoperiod
disruption is signiﬁcantly worsened,17–19 and our ﬁndings
that rhythmic gene expression is BMAL1-dependent shows
the circadian clock regulates important processes in the
pathologic state. This highlights the underappreciated role
of 24-hour timing in gastrointestinal illness, and future
studies need to be done to test connections between
photoperiod and disease etiology and progression. Although
our work has been carried out in LD photoperiod where
environmental light could induce diurnal changes that are
not a direct function of clock activity, because we observe
diurnal changes in the BMAL1þ/þ intestine that are not
present in BMAL1-/-, the effects we report are unlikely to be
a simple response to environmental change. Our data
highlight the importance of photoperiod on the mechanisms
underlying disease. Current treatment regimens may be able
to apply these and future insights from circadian biology.65
Moreover, it will be critical to account for circadian rhythmicity, and time-of-day dependency, in the use of animal
models to study the biology and treatment of gastrointestinal disease.

References
1. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.
Nature 2011;474:318–326.

Cellular and Molecular Gastroenterology and Hepatology Vol. 4, No. 1
2. Metcalfe C, Kljavin NM, Ybarra R, de Sauvage FJ. Lgr5þ
stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 2014;14:149–159.
3. Tian H, Biehs B, Warming S, Leong KG, Rangell L,
Klein OD, de Sauvage FJ. A reserve stem cell population
in small intestine renders Lgr5-positive cells dispensable.
Nature 2011;478:255–259.
4. Dubois A, Walker RI. Prospects for management of
gastrointestinal injury associated with the acute radiation
syndrome. Gastroenterology 1988;95:500–507.
5. Kirsch DG, Santiago PM, di Tomaso E, Sullivan JM,
Hou WS, Dayton T, Jeffords LB, Sodha P, Mercer KL,
Cohen R, Takeuchi O, Korsmeyer SJ, Bronson RT,
Kim CF, Haigis KM, Jain RK, Jacks T. p53 controls
radiation-induced gastrointestinal syndrome in mice
independent of apoptosis. Science 2010;327:593–596.
6. Somosy Z, Horvath G, Telbisz A, Réz G, Pálﬁa Z.
Morphological aspects of ionizing radiation response of
small intestine. Micron 2002;33:167–178.
7. Scheving LA. Biological clocks and the digestive system.
Gastroenterology 2000;119:536–549.
8. Masri S, Sassone-Corsi P. The circadian clock: a
framework linking metabolism, epigenetics and neuronal
function. Nat Rev Neurosci 2013;14:69–75.
9. Bunger MK, Wilsbacher LD, Moran SM, Clendenin C,
Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS,
Bradﬁeld CA. Mop3 is an essential component of the
master circadian pacemaker in mammals. Cell 2000;
103:1009–1017.
10. Borgs L, Beukelaers P, Vandenbosch R, Belachew S,
Nguyen L, Malgrange B. Cell “circadian” cycle: new role
for mammalian core clock genes. Cell Cycle 2009;
8:832–837.
11. Koike N, Yoo SH, Huang HC, Kumar V, Lee C, Kim TK,
Takahashi JS. Transcriptional architecture and chromatin
landscape of the core circadian clock in mammals. Science 2012;338:349–354.
12. Zhang R, Lahens NF, Ballance HI, Hughes ME,
Hogenesch JB. A circadian gene expression atlas in
mammals: Implications for biology and medicine. Proc
Natl Acad Sci U S A 2014;111:16219–16224.
13. Sladek M, Rybova M, Jindrakova Z, Zemanová Z,
Polidarová L, Mrnka L, O’Neill J, Pácha J, Sumová A.
Insight into the circadian clock within rat colonic
epithelial
cells.
Gastroenterology
2007;133:
1240–1249.
14. Polidarova L, Sotak M, Sladek M, Pacha J, Sumová A.
Temporal gradient in the clock gene and cell-cycle
checkpoint kinase Wee1 expression along the gut.
Chronobiol Int 2009;26:607–620.
15. Hoogerwerf WA, Hellmich HL, Cornelissen G, Halberg F,
Shahinian VB, Bostwick J, Savidge TC, Cassone VM.
Clock gene expression in the murine gastrointestinal
tract: endogenous rhythmicity and effects of a feeding
regimen. Gastroenterology 2007;133:1250–1260.
16. Hoogerwerf WA, Sinha M, Conesa A, Luxon BA,
Shahinian VB, Cornélissen G, Halberg F, Bostwick J,
Timm J, Cassone VM. Transcriptional proﬁling of mRNA
expression in the mouse distal colon. Gastroenterology
2008;135:2019–2029.

July 2017
17. Caruso CC, Lusk SL, Gillespie BW. Relationship of work
schedules to gastrointestinal diagnoses, symptoms, and
medication use in auto factory workers. Am J Ind Med
2004;46:586–598.
18. Segawa K, Nakazawa S, Tsukamoto Y, Kurita Y, Goto H,
Fukui A, Takano K. Peptic ulcer is prevalent among shift
workers. Dig Dis Sci 1987;32:449–453.
19. Schernhammer ES, Laden F, Speizer FE, Willett WC,
Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. Night-shift
work and risk of colorectal cancer in the nurses’ health
study. J Natl Cancer Inst 2003;95:825–828.
20. Preuss F, Tang Y, Laposky AD, Arble D, Keshavarzian A,
Turek FW. Adverse effects of chronic circadian
desynchronization in animals in a “challenging” environment. Am J Physiol Regul Integr Comp Physiol 2008;
295:R2034–R2040.
21. Shukla P, Gupta D, Bisht SS, Pant MC, Bhatt ML,
Gupta R, Srivastava K, Gupta S, Dhawan A, Mishra D,
Negi MP. Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma. Cancer 2010;116:2031–2035.
22. Reppert SM, Weaver DR. Coordination of circadian
timing in mammals. Nature 2002;418:935–941.
23. Sato T, Clevers H. Primary mouse small intestinal epithelial cell cultures. Methods Mol Biol 2013;945:319–328.
24. Montgomery RK, Carlone DL, Richmond CA, Farilla L,
Kranendonk ME, Henderson DE, Baffour-Awuah NY,
Ambruzs DM, Fogli LK, Algra S, Breault DT. Mouse
telomerase reverse transcriptase (mTert) expression
marks slowly cycling intestinal stem cells. Proc Natl Acad
Sci U S A 2011;108:179–184.
25. Sigdestad CP, Bauman J, Lesher SW. Diurnal ﬂuctuations in the number of cells in mitosis and DNA synthesis
in the jejunum of the mouse. Exp Cell Res 1969;
58:159–162.
26. Potten CS, Al-Barwari SE, Hume WJ, Searle J. Circadian
rhythms of presumptive stem cells in three different
epithelia of the mouse. Cell Tissue Kinet 1977;10:557–568.
27. Kondratov RV, Kondratova AA, Gorbacheva VY,
Vykhovanets OV, Antoch MP. Early aging and agerelated pathologies in mice deﬁcient in BMAL1, the
core component of the circadian clock. Genes Dev 2006;
20:1868–1873.
28. Matsu-Ura T, Dovzhenok A, Aihara E, Rood J, Le H,
Ren Y, Rosselot AE, Zhang T, Lee C, Obrietan K,
Montrose MH, Lim S, Moore SR, Hong CI. Intercellular
coupling of the cell cycle and circadian clock in adult
stem cell culture. Mol Cell 2016;64:900–912.
29. Leblond CP, Stevens CE. The constant renewal of the
intestinal epithelium in the albino rat. Anat Rec 1948;
100:357–377.
30. Bertalanffy FD. Mitotic rates and renewal times of the
digestive tract epithelia in the rat. Acta Anat (Basel) 1960;
40:130–148.
31. Yoshida D, Aoki N, Tanaka M, Aoyama S, Shibata S. The
circadian clock controls ﬂuctuations of colonic cell proliferation during the light/dark cycle via feeding behavior
in mice. Chronobiol Int 2015:1–11.
32. Punia S, Rumery KK, Yu EA, Lambert CM, Notkins AL,
Weaver DR. Disruption of gene expression rhythms in

BMAL1 and Intestinal Regeneration

33.

34.

35.

36.

37.

38.

39.

40.

41.

42.

43.

44.

45.

46.

113

mice lacking secretory vesicle proteins IA-2 and IA2beta. Am J Physiol Endocrinol Metab 2012;
303:E762–E776.
Balsalobre A, Marcacci L, Schibler U. Multiple signaling
pathways elicit circadian gene expression in cultured
Rat-1 ﬁbroblasts. Curr Biol 2000;10:1291–1294.
Lee C, Etchegaray JP, Cagampang FR, Loudon AS,
Reppert SM. Posttranslational mechanisms regulate the
mammalian circadian clock. Cell 2001;107:855–867.
Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH,
Buhr ED, Siepka SM, Hong HK, Oh WJ, Yoo OJ,
Menaker M, Takahashi JS. PERIOD2::LUCIFERASE realtime reporting of circadian dynamics reveals persistent
circadian oscillations in mouse peripheral tissues. Proc
Natl Acad Sci U S A 2004;101:5339–5346.
Moore SR, Pruszka J, Vallance J, Aihara E,
Matsuura T, Montrose MH, Shroyer NF, Hong CI.
Robust circadian rhythms in organoid cultures from
PERIOD2::LUCIFERASE mouse small intestine. Dis
Model Mech 2014;7:1123–1130.
Gaddameedhi S, Reardon JT, Ye R, Ozturk N, Sancar A.
Effect of circadian clock mutations on DNA damage
response in mammalian cells. Cell Cycle 2012;
11:3481–3491.
Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F,
Okamura H. Control mechanism of the circadian clock
for timing of cell division in vivo. Science 2003;
302:255–259.
Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian
gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;
111:41–50.
Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The
molecular clock mediates leptin-regulated bone formation. Cell 2005;122:803–815.
Curtis AM, Bellet MM, Sassone-Corsi P, O’Neill LA.
Circadian clock proteins and immunity. Immunity 2014;
40:178–186.
Keller M, Mazuch J, Abraham U, Eom GD, Herzog ED,
Volk HD, Kramer A, Maier B. A circadian clock in macrophages controls inﬂammatory immune responses.
Proc Natl Acad Sci U S A 2009;106, 21407–21012.
Bellet MM, Deriu E, Liu JZ, Grimaldi B, Blaschitz C,
Zeller M, Edwards RA, Sahar S, Dandekar S, Baldi P,
George MD, Raffatellu M, Sassone-Corsi P. Circadian
clock regulates the host response to Salmonella. Proc
Natl Acad Sci U S A 2013;110:9897–9902.
Gibbs JE, Blaikley J, Beesley S, Matthews L,
Simpson KD, Boyce SH, Farrow SN, Else KJ, Singh D,
Ray DW, Loudon AS. The nuclear receptor REVERBalpha mediates circadian regulation of innate
immunity through selective regulation of inﬂammatory
cytokines. Proc Natl Acad Sci U S A 2012;109:582–587.
Castanon-Cervantes O, Wu M, Ehlen JC, Paul K,
Gamble KL, Johnson RL, Besing RC, Menaker M,
Gewirtz AT, Davidson AJ. Dysregulation of inﬂammatory
responses by chronic circadian disruption. J Immunol
2010;185:5796–5805.
Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in
intestinal epithelium is orchestrated by the circadian

114

47.

48.

49.
50.

51.

52.

53.

54.

55.

56.

57.

58.
59.

Stokes et al
clock and microbiota cues transduced by TLRs. Cell
2013;153:812–827.
Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF,
Karin M. The two faces of IKK and NF-kappaB inhibition:
prevention of systemic inﬂammation but increased local
injury following intestinal ischemia-reperfusion. Nat Med
2003;9:575–581.
Lau KS, Cortez-Retamozo V, Philips SR, Pittet MJ,
Lauffenburger DA, Haigis KM. Multi-scale in vivo systems analysis reveals the inﬂuence of immune cells on
TNF-alpha-induced apoptosis in the intestinal epithelium. PLoS Biol 2012;10:e1001393.
Wajant H, Pﬁzenmaier K, Scheurich P. Tumor necrosis
factor signaling. Cell Death Differ 2003;10:45–65.
Vlantis K, Wullaert A, Sasaki Y, Schmidt-Supprian M,
Rajewsky K, Roskams T, Pasparakis M. Constitutive
IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J Clin Invest 2011;
121:2781–2793.
Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E,
Spencer-Dene B, Behrens A. JNK signalling modulates
intestinal homeostasis and tumourigenesis in mice.
EMBO J 2009;28:1843–1854.
Abe T, Sakaue-Sawano A, Kiyonari H, Shioi G, Inoue K,
Horiuchi T, Nakao K, Miyawaki A, Aizawa S, Fujimori T.
Visualization of cell cycle in mouse embryos with Fucci2
reporter directed by Rosa26 promoter. Development
2013;140:237–246.
Pilgrim C, Erb W, Maurer W. Diurnal ﬂuctuations in the
numbers of DNA synthesizing nuclei in various mouse
tissues. Nature 1963;199:863.
Karpowicz P, Zhang Y, Hogenesch JB, Emery P,
Perrimon N. The circadian clock gates the intestinal stem
cell regenerative state. Cell Rep 2013;3:996–1004.
Griniatsos J, Michail OP, Theocharis S, Arvelakis A,
Papaconstantinou I, Felekouras E, Pikoulis E,
Karavokyros I, Bakoyiannis C, Marinos G, Bramis J,
Michail PO. Circadian variation in expression of G1
phase cyclins D1 and E and cyclin-dependent kinase
inhibitors p16 and p21 in human bowel mucosa. World J
Gastroenterol 2006;12:2109–2114.
Summa KC, Jiang P, Fitzpatrick K, Voigt RM, Bowers SJ,
Forsyth CB, Vitaterna MH, Keshavarzian A, Turek FW.
Chronic alcohol exposure and the circadian clock mutation exert tissue-speciﬁc effects on gene expression in
mouse hippocampus, liver, and proximal colon. Alcohol
Clin Exp Res 2015;39:1917–1929.
Rey G, Cesbron F, Rougemont J, Reinke H, Brunner M,
Naef F. Genome-wide and phase-speciﬁc DNA-binding
rhythms of BMAL1 control circadian output functions in
mouse liver. PLoS Biol 2011;9:e1000595.
Karin M, Clevers H. Reparative inﬂammation takes
charge of tissue regeneration. Nature 2016;529:307–315.
Tattoli I, Killackey SA, Foerster EG, Molinaro R,
Maisonneuve C, Rahman MA, Winer S, Winer DA,
Streutker CJ, Philpott DJ, Girardin SE. NLRX1 acts as an
epithelial-intrinsic tumor suppressor through the

Cellular and Molecular Gastroenterology and Hepatology Vol. 4, No. 1

60.

61.

62.

63.

64.

65.

modulation of TNF-mediated proliferation. Cell Rep
2016;14:2576–2586.
Nateri AS, Spencer-Dene B, Behrens A. Interaction of
phosphorylated c-Jun with TCF4 regulates intestinal
cancer development. Nature 2005;437:281–285.
Laranjeiro R, Tamai TK, Peyric E, Krusche P, Ott S,
Whitmore D. Cyclin-dependent kinase inhibitor p20
controls circadian cell-cycle timing. Proc Natl Acad Sci U
S A 2013;110:6835–6840.
van der Flier LG, van Gijn ME, Hatzis P, Kujala P,
Haegebarth A, Stange DE, Begthel H, van den Born M,
Guryev V, Oving I, van Es JH, Barker N, Peters PJ, van de
Wetering M, Clevers H. Transcription factor achaete
scute-like 2 controls intestinal stem cell fate. Cell 2009;
136:903–912.
Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T,
Göktuna SI, Ziegler PK, Canli O, Heijmans J,
Huels DJ, Moreaux G, Rupec RA, Gerhard M,
Schmid R, Barker N, Clevers H, Lang R, Neumann J,
Kirchner T, Taketo MM, van den Brink GR,
Sansom OJ, Arkan MC, Greten FR. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of
stem-cell-like properties. Cell 2013;152:25–38.
Brown SA. Circadian clock-mediated control of stem cell
division and differentiation: beyond night and day.
Development 2014;141:3105–3111.
Gumz ML. Taking into account circadian rhythm when
conducting experiments on animals. Am J Physiol Renal
Physiol 2016;310:F454–F455.

Received November 29, 2016. Accepted March 24, 2017.
Correspondence
Address correspondence to: Phillip Karpowicz, PhD, Department of Biological
Sciences, University of Windsor, Windsor, Ontario, Canada N9B 3P4. e-mail:
Phillip.Karpowicz@uwindsor.ca.
Acknowledgments
The authors thank Robert Montgomery, Alessio Tovaglieri, Samantha Stewart,
Diana Carlone, Fanny Zhou, and Lijie Jiang for their technical support and
valuable input, and Jennifer Gommerman and Dana Philpott for their help
with the manuscript. The contents of this article are solely the responsibility
of the authors and may not represent the ofﬁcial views of the sponsoring
agencies.
Author contributions
Kyle Stokes performed experiments and contributed to writing. Abrial Cooke
and Hanna Chang performed experiments. David R. Weaver performed and
analyzed experiments and contributed to writing. David T. Breault designed
the study and contributed to writing. Phillip Karpowicz designed the study,
performed and analyzed experiments, and contributed to writing.
Conﬂicts of interest
The authors disclose no conﬂicts.
Funding
Kyle Stokes was funded by the Canadian Institutes of Health Research. David
R. Weaver was supported by the National Institutes of Health (R01NS056125
and R21ES024684). David T. Breault was supported by the National
Institutes of Health (R01DK084056), the Intellectual and Developmental
Disabilities Research Center (P30HD18655), the Harvard Digestive Disease
Center (P30DK034854), and the Timothy Murphy Fund. Phillip Karpowicz
was funded by the Human Frontier in Science Program, the University of
Windsor, and the Seeds4Hope/Windsor Cancer Foundation. The FUCCI2
reporter mouse strain was generously provided by the RIKEN Center for Life
Science Technologies (Yokohama, Japan).

